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Abstract
Background Despite decreasing malaria burden in sub-Saharan Africa, fever in children is frequently attributed 
to malaria and empirically treated with antimalarial drugs. The 2010 WHO guidelines recommend laboratory 
conﬁ rmation of malaria before initiating therapy, but the uptake of these guidelines is slow. We determined frequency 
and predictors of malaria overtreatment in febrile children at two western Kenya rural hospitals in regions with varied 
malaria endemicity.
Methods We enrolled consecutive febrile children aged 6 months to 15 years presenting to Kisii Provincial (malaria 
endemicity: hypoendemic) or Homa Bay District (malaria endemicity: holoendemic) hospitals between March, 2012, 
and November, 2013. Detailed demographic, clinical, and laboratory data were collected, including physician diagnosis 
at admission and corresponding treatments. All children were screened for HIV with antibody or PCR testing, 
for malaria using smear microscopy and Paracheck Pf rapid diagnostic tests, and for invasive bacterial infections 
using blood culture. We determined the frequency of clinician-prescribed antimalarial treatment among those with 
negative smear and rapid diagnostic test results and evaluated independent predictors of overtreatment using 
multivariate logistic regression. Because the sites had marked diﬀ erences in underlying malaria endemicities that 
might impact clinician suspicion of parasitaemia, analyses were stratiﬁ ed and compared by site.
Findings Among the 1362 children enrolled (685 in Kisii and 677 in Homa Bay), 46 (6·7%) and 310 (45·8%) had 
laboratory-conﬁ rmed malaria in Kisii and Homa Bay, respectively (p<0·001). Among children without malaria, 7·0% 
and 57·2% were empirically prescribed antimalarials at Kisii and Homa Bay, respectively (p<0·001). Signiﬁ cant 
predictors of malaria overtreatment in Homa Bay included presence of more than one danger sign according to 
Integrated Management of Childhood Illness guidelines (adjusted odds ratio 8·47, 95% CI 4·81–14·89), fever lasting 
more than 7 days (4·94, 1·90–12·86), and fever greater than 390C (3·07, 1·58–5·96). The sensitivity of clinical malaria 
diagnosis (vs gold-standard laboratory-based diagnosis) was lower in Kisii than in Homa Bay (73·0% vs 95·3%, 
p<0·001), whereas speciﬁ city was higher in Kisii than in Homa Bay (93·2% vs 33·7%, p<0·001).
Interpretation Malaria was treated, despite negative laboratory testing, more frequently in Homa Bay than in Kisii, 
probably owing to underlying higher malaria prevalence. Despite availability of diagnostic testing, malaria prevalence 
appears to inﬂ uence the clinical management of children in Kenya and may result in missed opportunities 
to accurately diagnose alternative causes of fever. Strengthening health system use and adherence to existing 
treatment guidelines appears necessary, particularly in areas of high malaria endemicity.
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